Late Onset Alzheimer's Disease
NCT05010603
This study is recruiting at 12 US sites in 11 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Alzheimer Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 55 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Columbia University
- Last updated on ClinicalTrials.gov
- May 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
District of Columbia · 1
- University of Washington · Washington D.C., DC
Florida · 1
- University of Miami · Miami, FL
Illinois · 1
- Rush University · Aurora, IL
Indiana · 2
- Indiana University · Bloomington, IN
- NCRAD at Indiana University · Indianapolis, IN
Minnesota · 1
- Mayo Clinic · Rochester, MN
Missouri · 1
- Joanne Norton · St Louis, MO
New York · 1
- Columbia University Irving Medical Center · New York, NY
North Carolina · 1
- North Carolina State University · Raleigh, NC
Pennsylvania · 1
- University of Pittsburgh · Pittsburgh, PA
Texas · 1
- University of Texas Southwestern · Dallas, TX
Washington · 1
- University of Washington · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.